Phase
Condition
Tinnitus
Treatment
Placebo-Saline
incobotulinum toxin A
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Adults age 18 or older
Unilateral or bilateral tinnitus present for ≥ 2 months
A score >16 on the Tinnitus Handicap Inventory
Participants must be willing and able to provide informed consent.
Exclusion
Exclusion Criteria:
Patients with known hypersensitivity to any botulinum toxin product or to any of thecomponents in the formulation.
Patients who have received botulinum toxin injections for any medical reason within 4 months prior to screening.
Patients with infection at proposed injection sites.
Patients scheduled for neurological or otological surgery for chronic ear disease,vestibular schwannoma, meningioma, or skull base tumors.
Significant psychiatric history or associated diagnosis of major depression.
Women who are pregnant or breastfeeding.
Study Design
Connect with a study center
University of Minnesota
Minneapolis, Minnesota 55455
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.